News
CALGARY, Alberta, Aug. 27, 2026 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura” or the “Company”) today announced the filing on SEDAR+ of its condensed consolidated interim financial statements and Management’s Discussion and Analysis (together, the “Interim Filings”) for the interim period ended June 30, 2026 and 2025.
Originally published via Source Article.
CALGARY, Alberta, Aug. 27, 2026 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura” or the “Company”) today announced the filing on SEDAR+ of its condensed consolidated interim financial statements and Management’s Discussion and Analysis (together, the “Interim Filings”) for the interim period ended June 30, 2026 and 2025.
Originally published via Source Article.
First drilling at Copper Rand has returned intersections including 20.3m at 4.2g/t AuEq; In addition, the maiden drill program at Gwillim has intersected gold mineralisation in all holes
First drilling at Copper Rand has returned intersections including 20.3m at 4.2g/t AuEq; In addition, the maiden drill program at Gwillim has intersected gold mineralisation in all holes
Originally published via Source Article.
Les premiers forages à Copper Rand ont retourné des intersections incluant 20,3 m à 4,2 g/t ÉqAu; de plus, le programme de forage initial à Gwillim a recoupé une minéralisation aurifère dans tous les trous
Les premiers forages à Copper Rand ont retourné des intersections incluant 20,3 m à 4,2 g/t ÉqAu; de plus, le programme de forage initial à Gwillim a recoupé une minéralisation aurifère dans tous les trous
Originally published via Source Article.
First drilling at Copper Rand has returned intersections including 20.3m at 4.2g/t AuEq; In addition, the maiden drill program at Gwillim has intersected gold mineralisation in all holes
First drilling at Copper Rand has returned intersections including 20.3m at 4.2g/t AuEq; In addition, the maiden drill program at Gwillim has intersected gold mineralisation in all holes
Originally published via Source Article.
Les premiers forages à Copper Rand ont retourné des intersections incluant 20,3 m à 4,2 g/t ÉqAu; de plus, le programme de forage initial à Gwillim a recoupé une minéralisation aurifère dans tous les trous
Les premiers forages à Copper Rand ont retourné des intersections incluant 20,3 m à 4,2 g/t ÉqAu; de plus, le programme de forage initial à Gwillim a recoupé une minéralisation aurifère dans tous les trous
Originally published via Source Article.
Crown Point Announces Expiration of Concessions in Tierra Del Fuego
Originally published via Source Article.
CALGARY, Alberta, Aug. 27, 2026 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Inventronics Limited (TSX Venture: IVX), please note that certain language was inadvertently carried forward from the Company’s Q1 2026 press release. The corrected release follows:
Originally published via Source Article.
Marking two decades of service with a 4.8-star rating across more than 2,000 Google reviews, the family-owned London plumber breaks down the basement flooding risks worth checking before the next heavy rain, and the City of London grant that covers up to 90 percent of the fix.
Marking two decades of service with a 4.8-star rating across more than 2,000 Google reviews, the family-owned London plumber breaks down the basement flooding risks worth checking before the next heavy rain, and the City of London grant that covers up to 90 percent of the fix.
Originally published via Source Article.
MONTRÉAL, 27 août 2026 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (« Knight ») (TSX : GUD), société pharmaceutique panaméricaine (hors États-Unis), a annoncé aujourd’hui avoir déposé une demande supplémentaire auprès de l’ANVISA, l’agence brésilienne de réglementation de la santé, en vue d’obtenir l’autorisation d’une indication supplémentaire pour MINJUVI® (tafasitamab), en association avec le lénalidomide ajouté au R-CHOP (rituximab, cyclophosphamide, doxorubicine, vincristine et prednisone; Tafa-Len-R-CHOP), à titre de traitement de première intention chez les adultes atteints d’un lymphome diffus à grandes cellules B (DLBCL) ou d’un lymphome à cellules B de haut grade (HGBL) n’ayant reçu aucun traitement antérieur. La demande supplémentaire visant cette nouvelle indication a été sélectionnée pour un examen dans le cadre du Project Orbis.
Originally published via Source Article.
